Artificial seeding of the green seaweed Monostroma for cultivation

In Japan, the green seaweed Monostroma is an important source of humanfood. Monostroma nitidum Wittrock (Japanese name: hitoegusa) is cultivated in brackish waters and estuaries of central to southern Japan. The green seaweed Monostroma grows in the brackish water area in the upper part of the intertidal zone in the warm waters. Artificial seed culture began with the collection of many gametes in April. The resultant zygotes were allowed to adhere to plastic settlement boards (20 cm long and 10 cm wide). The zygoteboards were then cultured in tanks (1 ×2 ×0.5 m) with fertiliser in a controlled growth room (10–87 μmol photon m^-2s^-1). The cultivated zygotes on the board in the indoor tanks gradually increased in size from 10 to 40 μm in diameter during May to early August. Zygote growth became slowed at the end of August. The zygotesmatured in early September, and the plates were transferred into culture tanks in a dark room for dark treatment. Maturation of the zygote was promoted by providing dark conditions for two weeks. The production of a concentrated zoospore solution from the mature blades was achieved by adding fresh water at temperature 2–3 °C above that of the seeding vats. Zoospores were released in large numbers when exposed to strong irradiance of 100 μmol photon m^-2 s^-1 for 30 min. The zygotes produced flat unicellular fronds at the germling stage. The technology of artificial seed culture and zoospore release from the zygotes is based mainly on these experiments. This revised version was published online in August 2006 with corrections to the Cover Date.     

Solving the coastal eutrophication problem by large scale seaweed cultivation

Eutrophication is becoming a serious problem in coastal waters in many parts of the world. It induces the phytoplankton blooms including `Red Tides', followed by heavy economic losses to extensive aquaculture area. Some cultivated seaweeds have very high productivity and could absorb large quantities of N, P, CO₂, produce large amount of O₂ and have excellent effect on decreasing eutrophication. The author believes that seaweed cultivation in large scale should be a good solution to the eutrophication problem in coastal waters. To put this idea into practice, four conditions should be fulfilled: (a) Large-scale cultivation could be conducted within the region experiencing eutrophication. (b) Fundamental scientific and technological problems for cultivation should have been solved. (c) Cultivation should not impose any harmful ecological effects. (d) Cultivation must be economically feasible and profitable. In northern China, large-scale cultivation of Laminaria japonica Aresch. has been encouraged for years to balance the negative effects from scallop cultivation. Preliminary research in recent years has shown that Gracilaria lemaneiformis (Bory) Daws. and Porphyra haitanensis Chang et Zheng are the two best candidates for this purpose along the Chinese southeast to southern coast from Fujian to Guangdong, Guangxi and Hong Kong. Gracilaria tenuistipitata var. liui Chang et Xia is promising for use in pond culture condition with shrimps and fish.     

Evidence for the presence of plant growth regulators in commercial seaweed products

Although seaweeds and various seaweed products have been utilized in agricultural practices for many years, the precise mechanism by which they elicit their beneficial growth responses is still not fully understood. The amount of mineral nutrients in commercial preparations cannot account for the magnitude of the responses. Some other factor, such as the presence of endogenous plant growth regulators is, therefore, thought to be involved. This paper reviews the literature supporting evidence for the occurrence of plant hormones in commercial seaweed preparations.abbreviations SWC seaweed concentrate - PGR plant growth regulator - GC-MS gas chromatography/mass spectrometry - ¹H-NMR proton nuclear magnetic resonance - HPLC high performance liquid chromatography     

Integrated seaweed cultivation on an abalone farm in South Africa

Land-based abalone aquaculture in South Africa, based on the local species Haliotis midae, started in the early 1990s and has grown rapidly in the last decade, with 13 commercial farms now producing over 850 t per annum. Over 6,000 t per annum of kelp Ecklonia maxima are now harvested for this purpose, and some kelp beds are reaching maximum sustainable limits. Research into seaweed aquaculture as feed (Ulva and some Gracilaria) for abalone started in the late 1990s on the southeast coast (where there are no kelp beds) using abalone waste water. A growing body of evidence suggests that a mixed diet of kelp plus other seaweeds can give growth rates at least as good as compound feed, and can improve abalone quality and reduce parasite loads. A pilot scale Ulva lactuca and abalone integrated recirculation unit using 25% recirculation was designed and built on the south west coast of South Africa using one 12,000-L abalone tank containing 13,200 15 ± 2.5 g abalone, connected to two 3,000-L seaweed tanks containing an initial starting biomass of 10 kg of seaweed, replicated 3 times. In an 18-month period, there were no significant differences in abalone health or growth rates, sediment build up and composition, mobile macro fauna densities and species between the recirculation or the flow-through units. Transfer of oxygen generated by the seaweeds to the abalone tanks was poor, resulting in the recirculated abalone tanks having lower (33%) dissolved oxygen concentrations than a comparable flow-through abalone unit. Seaweed nutrient content and specific growth rates in the units were comparable to seaweeds cultivated in fertilized effluent (SGR = 3.2 ± 3.4%.day⁻¹; Yield = 0.2 ± 0.19 kg.m².day⁻¹). Indications were that at this low recirculation ratio the seaweeds in the units were nutrient limited and that there were no negative effects to the abalone being cultivated in such a recirculation unit at this recirculation ratio.     

Recombinant human lactoferrin: A valuable protein for pharmaceutical products and functional foods

Lactoferrin, the main iron-binding protein of milk, has biological activities that are essential for the newborn and are beneficial for adults. Given this beneficial effect, there is broad interest in exogenous sources of lactoferrin in human nutrition. Consequently, several transgenic approaches to produce lactoferrin have been achieved. However, the activity of heterologous lactoferrin cannot be assumed to identically mimic that of the homologous protein. Human lactoferrin obtained from yeast, transgenic cows, and rice has met the criteria of structural similarity, high yield, and ease of protein isolation. Human lactoferrin from Aspergillus awamori has been mainly directed to therapeutic uses with advanced phases of clinical trials currently in progress. In contrast, human lactoferrin produced in transgenic cows and rice brings the clear advantage of origins compatible with use in foods, although the approval for these applications is still in process.     

Medicinal and pharmaceutical uses of seaweed natural products: A review

In the last three decades the discovery of metabolites with biological activities from macroalgae has increased significantly. However, despite the intense research effort by academic and corporate institutions, very few products with real potential have been identified or developed. Based on Silverplatter MEDLINE and Aquatic Biology, Aquaculture & Fisheries Resources databases, the literature was searched for natural products from marine macroalgae in the Rhodophyta, Phaeophyta and Chlorophyta with biological and pharmacological activity. Substances that currently receive most attention from pharmaceutical companies for use in drug development, or from researchers in the field of medicine-related research include: sulphated polysaccharides as antiviral substances, halogenated furanones from Delisea pulchra as antifouling compounds, and kahalalide F from a species of Bryopsis as a possible treatment of lung cancer, tumours and AIDS. Other substances such as macroalgal lectins, fucoidans, kainoids and aplysiatoxins are routinely used in biomedical research and a multitude of other substances have known biological activities. The potential pharmaceutical, medicinal and research applications of these compounds are discussed.     

Bioactive compounds in seaweed: functional food applications and legislation

Seaweed is more than the wrap that keeps rice together in sushi. Seaweed biomass is already used for a wide range of other products in food, including stabilising agents. Biorefineries with seaweed as feedstock are attracting worldwide interest and include low-volume, high value-added products and vice versa. Scientific research on bioactive compounds in seaweed usually takes place on just a few species and compounds. This paper reviews worldwide research on bioactive compounds, mainly of nine genera or species of seaweed, which are also available in European temperate Atlantic waters, i.e. Laminaria sp., Fucus sp., Ascophyllum nodosum, Chondrus crispus, Porphyra sp., Ulva sp., Sargassum sp., Gracilaria sp. and Palmaria palmata. In addition, Undaria pinnatifida is included in this review as this is globally one of the most commonly produced, investigated and available species. Fewer examples of other species abundant worldwide have also been included. This review will supply fundamental information for biorefineries in Atlantic Europe using seaweed as feedstock. Preliminary selection of one or several candidate seaweed species will be possible based on the summary tables and previous research described in this review. This applies either to the choice of high value-added bioactive products to be exploited in an available species or to the choice of seaweed species when a bioactive compound is desired. Data are presented in tables with species, effect and test organism (if present) with examples of uses to enhance comparisons. In addition, scientific experiments performed on seaweed used as animal feed are presented, and EU, US and Japanese legislation on functional foods is reviewed.     

Bioavailability of seaweed iodine in human beings.

The major procedure used to correct iodine deficiency is the universal salt iodization by addition of iodide or iodate to salt with an iodine content varying from 7 to 100 mg/kg of salt depending on the country legislation. As an important fraction of consumers in the world prefers natural products over artificial ones, we investigated the industrial feasibility of naturally iodized salt using seaweed as source of iodine. We report the results of the iodine bioavailability in healthy subjects from two seaweeds: Laminaria hyperborea and Gracilaria verrucosa selected due to their high level in iodine as a mineral or an organic form and low levels of heavy metals. As a control we studied in a normal man the bioavailability of pure mineral iodine such as potassium iodide which was excellent i.e. 96.4% and of pure organic iodine such as monoiodotyrosine which was a little lower i.e. 80.0%. Iodine bioavailability from these two seaweeds was studied in nine normal subjects from Marseille (France) which is an iodine sufficient area based on a median urinary iodine level of 137 microg/day and innine normal subjects from Brussels (Belgium) who present a mild iodine deficiency with a value of 73 microg/day. The iodine bioavailability of Gracilaria verrucosa is better than for Laminaria hyperborea (101% versus 90% in Marseille, t=0.812, NS; 85% versus 61.5% in Brussels, t = 2.486, p = 0.024, S*). The urinary excretion of iodine is lower in Brussels than in Marseille for the same seaweed because part of the iodine is stored in the thyroid (101% versus 85% for Gracilaria verrucosa, t = 1.010, NS; 90% versus 61.5% for Laminaria hyperborea, t = 3.879, p= 0.001, S***).     

Essential role of seaweed cultivation in integrated multi-trophic aquaculture farms for global expansion of mariculture: an analysis

Ecologically friendly aquaculture crops, such as seaweeds, herbivores, omnivores, and detritivores can be cultured using relatively less of our limited natural resources and produce relatively less pollution. They also top FAO’s estimates of aquaculture crops for the 21st century. These crops already comprise nearly 90% of global aquaculture tonnage, >90% of all aquaculture production in China and >60% of production even in North America. Consumers prefer them, most likely due to their low prices. Production costs of organisms low on the food chain are low due to the ability of these organisms to efficiently utilize low-cost, mostly plant-based diets and to recycle their own waste. Thus, ecologically friendly aquaculture is not a dream but a dominant global reality. The less ecologically-friendly aquaculture of salmon, sea bream, fed shrimp, among others, has attracted public opposition to aquaculture, but these crops totaled approximately only 10% of global production in 2004. The profitability of industrialized monocultures of these crops is threatened further by rising costs of energy and feed, environmental regulation compliance, disease, and public opposition. Current monoculture practices and perceptions intrinsic to the aquaculture industry can be turned around into a vision of sustained profitable expansion of carnivores production with trophically lower organisms in ecologically-balanced aquaculture farms. This category of aquaculture, which is the modern intensive form of polyculture practiced in Asia, feeds the waste of carnivore culture to lower trophic level organisms, primarily algae and mollusks. Species are selected based on their ecological functions in addition to their economic potential. Ecologically-balanced farms turn the costly treatment of carnivore waste outside the farm to a revenue-generating process of biofiltration, conversion, and resource recovery into plant and mollusk crops inside the farm. In doing so, they solve several of the major problems faced by modern aquaculture. The aquaculture industry can protect its own interests – and reap major benefits – by understanding the importance of ecological balance, the potential of seaweeds as components in feeds, and the importance of the culture and R&D of low trophic level organisms. The industry should also accept the relevance of environmental, social, and image aspects of aquaculture to its success. Governments have the tools to reward multi-trophic farms with seaweeds by means of tax credits and nutrient credits and to penalize unbalanced monoculture approaches by means of ‘polluter pays’ fines, thereby providing the multi-trophic farms with a significant economic advantage. Such measures have been discussed, but their implementation has been slow.     

Ethno biological usage of zoo products in rheumatoid arthritis

Rheumatoid arthritis (RA) is one of the most common autoimmune disorder which causes swelling, redness, pain, stiffness, restriction of limb movements, decreases life expectancy and early death of the patients. Available drugs include non steroidal anti-inflammatory and analgesics, disease modifying anti-rheumatic drugs and steroids (glucocorticoids etc). All these drugs have their own limitations such as gastrointestinal irritations, cardiovascular problems, and drug dependency. Search for alternative therapy from natural products are being ventured throughout the world. Zoo therapy in arthritis, a common practice of the ancient times that have been mentioned in traditional and folk medicine. The scientific basis of some of the zoo products are being explored and have been showing promising results in experimental rheumatoid arthritis. These therapies have minimum side effects and many of them have potential to give rise to drug development clues against rheumatoid arthritis. The present review is an effort to establish the folk and traditional treatment of rheumatoid arthritis using zoo products.     

Improved performance with multiple fermentors for repeated batch cultivation for non-growth-associated products

Based on batch cultivation data for the production of L-glutamic acid from glucose, a comparative evaluation was made for repeated batch cultivations using one and more fermentors. The problem was formulated as maximizing the productivity of metabolic product with the specified conversion with respect to the cell age and the volume fraction used as seed for the subsequent repeated batch cultivation. Simulations were carried out with the assumption of no lag in product formation for the cases where the total operation time was specified as 200 h with reproducible batch cultivation cycles. The product production was assumed to be solely a function of product concentration. The computation results show the advantage of using more than one fermentor from the viewpoints of productivity and conversion, which will apply in general to non-growth-associated product production with delay time. In particular, three fermentors are recommended for the production of L-glutamic acid chosen as an example in this article.     

Homogeneous cultivation of animal cells for the production of virus and virus products

Homogeneous technique facilitates the cultivation of large quantities of cells, reduces the risk of contamination by eliminating many manipulations, and makes practical the control of conditions such as pH and oxygen tension. Although most animal cells will not multiply in free suspension, certain cell lines have lost the requirement of being attached to a solid surface. These cells can be subcultured indefinitely but have some resemblance to cancer cells such as their abnormal karyotype. Certain cell linen developed from human embryonic tissue maintain their diploid character after repeated subculture and would seem to be ideal for the production of vaccines. However, strict regulations exist for viral products for human injection in that only cells taken from normal tissue and subcultured but once may be used. A microcarrier method in which cells adhere to DEAE-Sephadex beads permits a suspension culture which may be termed quasihomogeneous. The attached cells may be retained by sedimentation or by screening as the medium is replaced. Cell debirs from the original tissue is difficult to remove from microcarrier cultures; modifications of the trypsinization technique have alleviated but not solved this problem. Conditions for virus replication can be less critical than those for cell growth in that oxygen tension seems to have little influence on virus production. In cases where rate of virus production increases with specific growth rate of cells, homogeneous culture would have a advantage in maintaining a high cell mogeneous culture would have a valuble advantage in maintaining a high cell growth rate for a longer time. Some virus infections destroy cells, but others cause little change in cellular mteabolism except that virus is continually produced. The latter type can be conducted with a microcarrier in continuous culture with a virus titer exceeding 10⁷ plaque forming units per milliliter for over 50 days with Rubella-infected BHK cells.     

The possibility of useful usage of biodegradation products of sunflower plants

Heads of sunflower (Helianthus annuus L.) were first biodegraded at 55 degrees C by their microflora. Biodegradation products of sunflower heads (BPSH) were analyzed. They were found to contain 9.77% dry matter, 3.98% total ash, 3.18% crude protein and 5.75% total organic matter. BOD load was determined as 4.80 g/100 g. Subsequently, the effects of BPSH at various concentrations (1.0%, 2.5%, 10% and 100%) on the seed germination and some growth parameters of Phaseolus vulgaris L., Cicer arietinum L. and Triticum vulgare L. were investigated. The percentages of seed germination and germination index of seeds were similar between the control and 1.0% and 2.5% BPSH groups, but these values decreased at higher concentrations. On the other hand, growth of the seedlings gradually increased up to a concentration of 10% BPSH and decreased at 100% concentration. As a result, at concentrations up to 10% the product was found to be beneficial for growth of plants.     

Structural and functional characterization of gene products encoded in the human genome by homology detection

Availability of the human genome data has enabled the exploration of a huge amount of biological information encoded in it. There are extensive ongoing experimental efforts to understand the biological functions of the gene products encoded in the human genome. However, computational analysis can aid immensely in the interpretation of biological function by associating known functional/structural domains to the human proteins. In this article we have discussed the implications of such associations. The association of structural domains to human proteins could help in prioritizing the targets for structure determination in the structural genomics initiatives. The protein kinase family is one of the most frequently occurring protein domain families in the human proteome while P-loop hydrolase, which comprises many GTPases and ATPases, is a highly represented superfamily. Using the superfamily relationships between families of unknown and known structures we could increase structural information content of the human genome by about 5%. We could also make new associations of domain families to 33 human proteins that are potentially linked to genetically inherited diseases.     

Diatom cultivation and biotechnologically relevant products. Part II: Current and putative products

While diatoms are widely present in terms of diversity and abundance in nature, few species are currently used for biotechnologically applications. Most studies have focussed on intracellularly synthesised eicosapentaenoic acid (EPA), a polyunsaturated fatty acid (PUFA) used for pharmaceutical applications. Applications for other intracellular molecules, such as total lipids for biodiesel, amino acids for cosmetic, antibiotics and antiproliferative agents, are at the early stage of development. In addition, the active principle component must be identified amongst the many compounds of biotechnological interest. Biomass from diatom culture may be applied to: (1). aquaculture diets, due to the lipid- and amino-acid-rich cell contents of these microorganisms, and (2). the treatment of water contaminated by phosphorus and nitrogen in aquaculture effluent, or heavy metal (bioremediation). The most original application of microalgal biomass, and specifically diatoms, is the use of silicon derived from frustules in nanotechnology. The competitiveness of biotechnologically relevant products from diatoms will depend on their cost of production. Apart from EPA, which is less expensive when obtained from Phaeodactylum tricornutum than from cod liver, comparative economic studies of other diatom-derived products as well as optimisation of culture conditions are needed. Extraction of intracellular metabolites should be also optimised to reduce production costs, as has already been shown for EPA. Using cell immobilisation techniques, benthic diatoms can be cultivated more efficiently allowing new, biotechnologically relevant products to be investigated.